Key technologies and capabilities for this role
Common questions about this position
The expected salary is $23.25 per hour for the role performed in Illinois (CHI), and it may vary for other locations like California, Colorado, or New York based on qualifications and experience.
The potential available shift is Tuesday-Wednesday and Friday-Saturday from 9a-7:30p, with shift assignment based on technical level, experience, and current business needs. Candidates must be able to work the assigned shift.
A 4-year college degree in a Biological Science including classes in anatomy and/or molecular biology is required, along with prior Pathology or Histotechnology Lab experience (anatomy experience highly preferred), knowledge of medical terminology (highly preferred), exceptional interpersonal skills, high organization, attention to detail, and computer proficiency.
Tempus offers a full range of benefits, which may include incentive compensation, restricted stock units, medical and other benefits depending on the position.
Strong candidates will have prior Pathology or Histotechnology Lab experience, knowledge of medical terminology, exceptional interpersonal and communication skills, high organization with attention to detail, and the ability to show initiative in a fast-paced environment while working independently on mission-critical tasks.
AI-driven healthcare data analysis platform
Tempus focuses on enhancing patient outcomes through the use of data and artificial intelligence in healthcare. The company offers a platform that analyzes medical data to provide insights for physicians, helping them make better treatment decisions. This platform also aids pharmaceutical and biotech companies in drug development by identifying new targets and assessing treatment effectiveness. For patients, Tempus identifies personalized therapy options, particularly in cancer care, where their research has shown increased opportunities for tailored treatments. They have developed a pan-cancer organoid platform and a liquid biopsy assay for profiling circulating tumor DNA. Tempus generates revenue by charging healthcare providers and companies for access to their platform and insights, setting them apart from competitors by their focus on personalized medicine and extensive cancer research.